You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AZA-AML-004

Showing 1 - 25 of 1,952
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • chidamide and azacitidine
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Sep 27, 2023

Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Suzhou, Jiangsu, China
  • +1 more
Aug 18, 2022

Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Leipzig, Germany
    Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Leukemia, Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia Trial in Tianjin (MAX-40279-01)

Recruiting
  • Leukemia
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 29, 2021

Acute Myeloid Leukemia Trial in Marseille, Nice (Pharmacokinetic sampling, Vital status determination, Toxicity assessments)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Pharmacokinetic sampling
  • +3 more
  • Marseille, France
  • +1 more
Sep 6, 2023

Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • NanJing, China
    Department of Hematology, Zhongda Hospital, Medical School of So
Sep 2, 2022

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Combined With Venetoclax and ATRA group
  • Suzhou, China
    the First Affiliated Hospital of Soochow University
Dec 8, 2022

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

Leukemia Trial in Houston (Brentuximab Vedotin, 5-Azacytidine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 7, 2022

Acute Myeloid Leukemia in Remission Trial in Nanjing (Azacitidine, Lenalidomide)

Recruiting
  • Acute Myeloid Leukemia in Remission
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Mar 23, 2022

Acute Myelogenous Leukemia Trial in Rochester (Decitabine)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Rochester, New York
    University of Rochester
Jul 1, 2022

Refractory Acute Myeloid Leukemia Trial in Shanghai (Aza-Ven-allo-HSCT)

Recruiting
  • Refractory Acute Myeloid Leukemia
  • Shanghai, China
  • +2 more
May 27, 2021

Acute Myeloid Leukemia Trial in Italy (Vidaza 100 milligram (mg) injection, Best Supportive Care)

Completed
  • Acute Myeloid Leukemia
  • Vidaza 100 milligram (mg) injection
  • Best Supportive Care
  • Alessandria, AL, Italy
  • +17 more
Jan 13, 2022

Acute Myeloid Leukemia in Remission, MDS, Minimal Residual Disease Trial in Germany (Pevonedistat, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia in Remission
  • +2 more
  • Aachen, Germany
  • +13 more
Jul 11, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +4 more
Sep 14, 2021

Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • The combination of HHT, venetoclax, AZA, G-CSF
  • (no location specified)
Mar 28, 2021

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • STAT Inhibitor OPB-111077
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 20, 2022

Blasts More Than 20 Percent of Bone Marrow Nucleated Cells, Blasts More Than 20 Percent of Peripheral Blood White Cells,

Completed
Has Results
  • Blasts More Than 20 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Acute Myeloid Leukemia (AML), MDS(MDS) Trial in China (TJ011133)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes(MDS)
  • Beijing, Beijing, China
  • +25 more
Jul 29, 2021